Tag Archives: AstraZeneca

Crowdsourcing: two approaches, two different outcomes

In my July 16 post, I set out to prove that crowdsourcing is a very cost-effective tool allowing solving problems at much less cost compared to other innovation tools, and, therefore, the low popularity of crowdsourcing, of which I wrote … Continue reading

Posted in Crowdsourcing | Tagged , , , , , , , , , , , , , , , , , , , , , , | 4 Comments

The Terminator Effect

(This post originally appeared on Innovation Excellence) I’d like to touch upon a subject that doesn’t come up often in innovation discussions: I’d like to talk about how we kill projects. Everyone would agree that killing projects is a key to … Continue reading

Posted in Portfolio Management | Tagged , , , , , , , , , | 2 Comments